SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...

At the Yale Positron Emission Tomography (PET) Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in brain PET imaging. With a ...

New research appears to confirm that positron emission tomography (PET) imaging using the [F-18] FDDNP tracer can identify the distinctive brain tau pathology of chronic traumatic encephalopathy (CTE) ...

The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...

A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of Nuclear Medicine. The ...

QST team Members of the Imaging Physics Group with the total-body small-animal PET scanner. (Courtesy: Han Gyu Kang) Dynamic PET imaging is an important preclinical research tool used to visualize ...

Imagine being able to see the invisible-amyloid plaques, tau tangles, and metabolic changes in the living brain. This is no ...

SEOUL, South Korea, July 31, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

SynuSight Biotech ("SynuSight"), a biotechnology company dedicated to the development of diagnostic solutions for neurodegenerative diseases and ABLi Therapeutics ("ABLi"), a biotechnology company ...